About this Event
Sickle Cell Disease Symposium
Achieving the Sustainable Development Goals (SDGs) for health in Africa necessitates addressing sickle cell disease (SCD), a chronic non-communicable disorder that disproportionately affects the continent, with Africa accounting for 80% of the global SCD population and over 300,000 new cases annually. Despite challenges in healthcare systems, groundbreaking advances in genomics, including the Human Genome Project and gene editing technologies, offer promising pathways for curing SCD through gene therapy. Tanzania has emerged as a leader by hosting global forums on SCD at the Scientific Summit of the United Nations General Assembly (UNGA) and other international platforms, facilitating crucial dialogue among global leaders to enhance health outcomes. The 2024 UNGA SCD event aims to convene key stakeholders to strategize on a global response to SCD. This event is a collaborative effort involving Muhimbili University of Health and Allied Sciences (MUHAS), New York University (NYU) Institute for Excellence in Health Equity, NYU Africa House, NYU Implementing Sustainable Evidence-based Interventions through Engagement (ISEE) Lab, and other international partners dedicated to advancing health equity and scientific innovation
This is a hybrid event. Registration to attend inperson closes September 18th. All other registrations thereafter will be for virtual access to the event. For those who have selected virtual, will receive a separate email to complete a zoom registration. All other registrations thereafter will be for virtual access to the event.
Event Venue & Nearby Stays
708 Broadway, 708 Broadway, New York, United States
USD 0.00